A study led by Dr. Steven Monda at the University of Michigan, published in JAMA Oncology, found that the number of men undergoing surgery for low-risk prostate cancer dropped by more than fivefold from 2010 to 2024. The decline is attributed to improvements in diagnostic tools and an increase in active surveillance, which helps many patients avoid unnecessary procedures. Discover how Michigan’s MUSIC initiative is setting a national example for reducing unnecessary treatments and promoting personalized care.
